Iclaprim

iclaprim · Arpida AG

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Iclaprim, covering 2007-03-27 to 2018-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 [Phase 3]